Literature DB >> 22008490

P wave signal-averaged ECG in normal population and in patients with converted atrial fibrillation.

Constantin Militaru1, Ionut Donoiu, Dan-Dominic Ionescu.   

Abstract

BACKGROUND: Signal-averaged electrocardiography of the P wave (P wave SAECG) is a noninvasive method for evaluating the risk of atrial fibrillation (AF). We aimed to study P wave SAECG parameters in a large number of apparently healthy subjects and to compare them with patients with converted AF.
METHODS: We examined 591 individuals; P wave SAECG were recorded in 330 normal subjects, 31 patients with converted persistent AF and 57 patients with converted paroxysmal AF immediately after conversion, at 12 and 24 hours after conversion, then after 3 and 6 months. P wave SAECG were recorded using a commercially available machine aiming to obtain a noise level <1 μV.
RESULTS: In the normal population the duration of the filtered P wave (PWD) was higher in men. P wave duration, RMS(40) and RMS(30) were significantly correlated with age. By comparing the normal population with patients with persistent AF converted to sinus rhythm we demonstrated significant differences in PWD and P wave integral. Patients with recurrent persistent AF had significantly higher PWD. The study of patients with paroxysmal AF, compared to the control group, showed significant increase of the same parameters: PWD and integral of the P wave. Patients with recurrent paroxysmal AF had higher PWD and lower RMS(40) , RMS(30) , RMS(20) .
CONCLUSIONS: Filtered P wave duration was higher in men; PWD was weakly but significantly correlated with age. Patients with paroxysmal or persistent AF converted to sinus rhythm had significantly higher P wave duration and P wave integral. ©2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22008490      PMCID: PMC6932409          DOI: 10.1111/j.1542-474X.2011.00462.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  8 in total

1.  [P-wave signal averaging-ECG: normal values and reproducibility].

Authors:  J R Ehrlich; G Q Zhang; C W Israel; S H Hohnloser
Journal:  Z Kardiol       Date:  2001-03

2.  The signal-averaged electrocardiogram of atrial activation in patients with or without paroxysmal atrial fibrillation.

Authors:  José Osvaldo Moreira; Paulo Jorge Moffa; Augusto Hiroshi Uchida; Nancy Maria Martins de Oliveira Tobias; César José Grupi; Bráulio Luna Filho; Flávio Tarasoutchi
Journal:  Arq Bras Cardiol       Date:  2006-11       Impact factor: 2.000

3.  Immediate and short-term reproducibility of the P wave signal-averaged electrocardiogram.

Authors:  F A Ehlert; N Zaman; J S Steinberg
Journal:  Pacing Clin Electrophysiol       Date:  1997-06       Impact factor: 1.976

4.  Signal-averaged P-wave analysis of normal controls and patients with paroxysmal atrial fibrillation: a study in gender differences, age dependence, and reproducibility.

Authors:  Anwer Dhala; Donald Underwood; Robert Leman; Ernest Madu; Dainia Baugh; Yukio Ozawa; Yuji Kasamaki; Qiuzhen Xue; Shankara Reddy
Journal:  Clin Cardiol       Date:  2002-11       Impact factor: 2.882

5.  P wave dispersion and P wave duration on SAECG in predicting atrial fibrillation in patients with acute myocardial infarction.

Authors:  Marcin Rosiak; Halina Bolinska; Jan Ruta
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

6.  Reverse electrical remodeling of the atria post cardioversion in patients who remain in sinus rhythm assessed by signal averaging of the P-wave.

Authors:  Nagib Chalfoun; David Harnick; Elena Pe; Manish Undavia; Davendra Mehta; J Anthony Gomes
Journal:  Pacing Clin Electrophysiol       Date:  2007-04       Impact factor: 1.976

7.  Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery.

Authors:  J S Steinberg; S Zelenkofske; S C Wong; M Gelernt; R Sciacca; E Menchavez
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

8.  Reversal atrial electrical remodeling following cardioversion of long-standing lone atrial fibrillation.

Authors:  Eduardo Correa Barbosa; Paulo Roberto Benchimol-Barbosa; Alfredo de Souza Bomfim; Plínio José da Rocha; Silvia Helena Cardoso Boghossian; Denilson Campos de Albuquerque
Journal:  Arq Bras Cardiol       Date:  2009-09       Impact factor: 2.000

  8 in total
  6 in total

Review 1.  The year of 2011 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

2.  Usefulness of P-wave signal averaging to predict atrial fibrillation recurrences after electrical cardioversion.

Authors:  Coralie Blanche; Nam Tran; David Carballo; Fabio Rigamonti; Haran Burri; Marc Zimmermann
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-01-08       Impact factor: 1.468

3.  The impact of left atrial pressure on filtered P-wave duration in patients with atrial fibrillation.

Authors:  Hideyuki Kishima; Takanao Mine; Satoshi Takahashi; Kenki Ashida; Masaharu Ishihara; Tohru Masuyama
Journal:  Heart Vessels       Date:  2016-01-05       Impact factor: 2.037

4.  Atrial fibrillation recurrence predictors after conversion to sinus rhythm.

Authors:  C Militaru; I Donoiu
Journal:  Curr Health Sci J       Date:  2014-03-29

5.  Automatically assessed P-wave predicts cardiac events independently of left atrial enlargement in patients with cardiovascular risks: The Japan Morning Surge-Home Blood Pressure Study.

Authors:  Ayako Yokota; Tomoyuki Kabutoya; Satoshi Hoshide; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-19       Impact factor: 3.738

6.  Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes' Hearts.

Authors:  Helge Servatius; Simon Raab; Babken Asatryan; Andreas Haeberlin; Mattia Branca; Stefano de Marchi; Nicolas Brugger; Nikolas Nozica; Eleni Goulouti; Elena Elchinova; Anna Lam; Jens Seiler; Fabian Noti; Antonio Madaffari; Hildegard Tanner; Samuel H Baldinger; Tobias Reichlin; Matthias Wilhelm; Laurent Roten
Journal:  J Clin Med       Date:  2022-02-27       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.